臨床試驗

Mobilization and Outcomes After Venous Closure

NCT：NCT07246902 · COMPLETED

NCT IDNCT07246902

狀態COMPLETED

開始日期2025-11-24

完成時間2026-08-26

SponsorCordis US Corp. (INDUSTRY)

First posted2025-11-24

Last updated2026-09-18

簡要摘要

The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。